Bevacizumab: Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF

被引：0
|
作者：
不详
机构：
来源：
Drugs in R & D | 2002年 / 3卷 / 1期
关键词：
Bevacizumab; Irinotecan; Metastatic Breast Cancer; Folinic Acid; Retinal Vein Occlusion;
D O I：
10.2165/00126839-200203010-00006
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：28 / 30
页数：2
相关论文
共 50 条
  • [31] Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma
    Kasuya, Kazuhiko
    Nagakawa, Yuichi
    Suzuki, Minako
    Suzuki, Yoshiaki
    Kyo, Bunso
    Suzuki, Satoru
    Matsudo, Takaaki
    Itoi, Takao
    Tsuchida, Akihiko
    Aoki, Tatsuya
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (04) : 599 - 602
  • [32] Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice
    Yagi, Yasumichi
    Fushida, Sachio
    Harada, Shinichi
    Tsukada, Tomoya
    Kinoshita, Jun
    Oyama, Katsunobu
    Fujita, Hideto
    Ninomiya, Itasu
    Fujimura, Takashi
    Kayahara, Masato
    Kinuya, Seigo
    Yashiro, Masakazu
    Hirakawa, Kousei
    Ohta, Tetsuo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 745 - 753
  • [33] Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD
    Schaal, K. B.
    Engler, C.
    Schuett, F.
    Scheuerle, A.
    Dithmar, S.
    OPHTHALMOLOGE, 2008, 105 (06): : 538 - +
  • [34] Anti-VEGF Therapy with Bevacizumab - Limited Cardiovascular Toxicity
    Yu, Jing
    Cao, Xu-Fen
    Zheng, Ye
    Zhao, Rong-Cheng
    Yan, Li-Qiu
    Zhao, Lei
    Wang, Jia-Wang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10769 - 10772
  • [35] Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
    Krizova, Deli
    Vokrojova, Magdalena
    Liehneova, Katerina
    Studeny, Pavel
    JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [36] Effects of a human anti-VEGF antibody (Bevacizumab) on myopia development and choroidal thickness in the chicken
    Schaeffel, Frank
    Mathis, Ute
    Ziemssen, Focke
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [37] Psoriasis: Anti-VEGF antibody therapy for psoriasis?
    Buckland J.
    Nature Reviews Rheumatology, 2010, 6 (3) : 119 - 119
  • [38] VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
    Fushida, Sachio
    Oyama, Katsunobu
    Kinoshita, Jun
    Yagi, Yasumichi
    Okamoto, Kouichi
    Tajima, Hidehiro
    Ninomiya, Itasu
    Fujimura, Takashi
    Ohta, Tetsuo
    ONCOTARGETS AND THERAPY, 2013, 6 : 1445 - 1451
  • [39] Phase I study of anti-VEGF monoclonal antibody bevacizumab and HDAC inhibitor valproic acid in patients with advanced cancers.
    Wheler, J. J.
    Janku, F.
    Jackson, T.
    Fu, S.
    Sun, M.
    Yang, H.
    Naing, A.
    Moulder, S. L.
    Tsimberidou, A. M.
    Hong, D. S.
    Falchook, G. S.
    Piha-Paul, S. A.
    Garcia-Manero, G.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies
    Bouziotis, P.
    Gourni, E.
    Xanthopoulos, S.
    Paravatou, M.
    Syrigos, K.
    Loudos, G.
    Archimandritis, S. C.
    Varvarigou, A. D.
    Harris, A. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S320 - S321
12345